AKT1 and lymphoma: The small-molecule 17-AAG (17-allylamino-17-demethoxygeldanamycin) can induce cell death in a dose- and time-dependent manner by reducing the cellular contents of critical survival proteins, including Akt and cyclin D1 in a range of lymphoma cell lines [216].